Kazuhiro Ogai Selected Research

Optic Nerve Injuries

10/2019	A novel activation mechanism of cellular Factor XIII in zebrafish retina after optic nerve injury.
1/2018	Alternative Splicing for Activation of Coagulation Factor XIII-A in the Fish Retina After Optic Nerve Injury.
11/2017	A novel function of neuroglobin for neuroregeneration in mice after optic nerve injury.
1/2016	A Possible Role of Neuroglobin in the Retina After Optic Nerve Injury: A Comparative Study of Zebrafish and Mouse Retina.
1/2014	Nipradilol promotes axon regeneration through S-nitrosylation of PTEN in retinal ganglion cells.
1/2014	Upregulation of leukemia inhibitory factor (LIF) during the early stage of optic nerve regeneration in zebrafish.
1/2014	Reciprocal changes in factor XIII and retinal transglutaminase expressions in the fish retina during optic nerve regeneration.
9/2013	Functional characterization of fish neuroglobin: zebrafish neuroglobin is highly expressed in amacrine cells after optic nerve injury and can translocate into ZF4 cells.
12/2012	Protective action of nipradilol mediated through S-nitrosylation of Keap1 and HO-1 induction in retinal ganglion cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuhiro Ogai Research Topics

Disease

9	Optic Nerve Injuries 10/2019 - 12/2012
3	Retinal Degeneration 01/2016 - 03/2015
2	Pressure Ulcer (Bedsore) 01/2022 - 07/2021
1	Cross Infection (Nosocomial Infection) 01/2022
1	Ulcer 07/2021
1	Wounds and Injuries (Trauma) 07/2021
1	Inflammation (Inflammations) 01/2021
1	Wound Infection (Wound Infections) 01/2021
1	Necrosis 04/2020
1	Suppuration 04/2020
1	Infections 12/2019
1	Skin Diseases (Skin Disease) 01/2019
1	Bone Resorption 11/2018
1	Hyperglycemia 01/2017
1	Melanoma (Melanoma, Malignant) 06/2015
1	Experimental Melanoma 06/2015
1	Neoplasms (Cancer) 05/2015

Drug/Important Bio-Agent (IBA)

3	Messenger RNA (mRNA)IBA 10/2019 - 09/2013
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2013
3	Retinaldehyde (Retinal)IBA 11/2017 - 01/2014
3	NeuroglobinIBA 11/2017 - 09/2013
3	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2016 - 03/2015
2	Factor XIII (Coagulation Factor XIII)IBA 10/2019 - 01/2018
1	CoagulaseIBA 01/2022
1	Oxygen (Dioxygen)IBA 07/2021
1	CytokinesIBA 04/2020
1	lauric acid (dodecanoic acid)IBA 12/2019
1	EphrinsIBA 11/2018
1	Peptides (Polypeptides)IBA 01/2018
1	CollagenIBA 01/2017
1	Alkylating AgentsIBA 01/2016
1	Amino Acids FDA Link 06/2015
1	Monophenol Monooxygenase (Tyrosinase)IBA 06/2015
1	Tyrosine (L-Tyrosine)FDA Link 06/2015
1	3-iodo-4-hydroxyphenylcysteineIBA 06/2015
1	Melanins (Melanin)IBA 06/2015
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 06/2015
1	EnzymesIBA 06/2015
1	Phenylthiourea (Phenylthiocarbamide)IBA 06/2015
1	ThymidineIBA 06/2015
1	Copper-64IBA 05/2015
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2014
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2014
1	TensinsIBA 01/2014
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 12/2012

Therapy/Procedure

1	Long-Term Care 01/2022
1	Skin Care 01/2021
1	Conservative Treatment 04/2020
1	Therapeutics 01/2019